Home/Filings/4/0001104659-17-003115
4//SEC Filing

MARINUS PHARMACEUTICALS INC 4

Accession 0001104659-17-003115

CIK 0001267813operating

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 5:19 PM ET

Size

7.7 KB

Accession

0001104659-17-003115

Insider Transaction Report

Form 4
Period: 2017-01-17
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
  • Award

    Restricted stock

    2017-01-17+60,60060,600 total
    Common Stock (60,600 underlying)
  • Award

    Stock option (right to buy)

    2017-01-17+141,400141,400 total
    Exercise: $1.21Exp: 2027-01-17Common Stock (141,400 underlying)
Footnotes (4)
  • [F1]Options to purchase shares of common stock vest in 36 equal monthly installments commencing 1/31/2017.
  • [F2]Each share of restricted stock represents the right to receive, at settlement, one share of common stock.
  • [F3]Shares of restricted stock vest in three equal annual installments of 20,200 on 1/17/18, 1/17/19 and 1/17/20.
  • [F4]Not applicable.

Documents

1 file

Issuer

MARINUS PHARMACEUTICALS INC

CIK 0001267813

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001267813

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:19 PM ET
Size
7.7 KB